JP2025515979A5 - - Google Patents
Info
- Publication number
- JP2025515979A5 JP2025515979A5 JP2024565108A JP2024565108A JP2025515979A5 JP 2025515979 A5 JP2025515979 A5 JP 2025515979A5 JP 2024565108 A JP2024565108 A JP 2024565108A JP 2024565108 A JP2024565108 A JP 2024565108A JP 2025515979 A5 JP2025515979 A5 JP 2025515979A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleotide sequence
- polynucleotide construct
- hybrid promoter
- podocyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22382421.0A EP4273243A1 (en) | 2022-05-02 | 2022-05-02 | Nucleic acid constructs and vectors for podocyte specific expression |
| EP22382421.0 | 2022-05-02 | ||
| PCT/EP2023/061388 WO2023213738A1 (en) | 2022-05-02 | 2023-04-28 | Nucleic acid constructs and vectors for podocyte specific expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515979A JP2025515979A (ja) | 2025-05-22 |
| JP2025515979A5 true JP2025515979A5 (enExample) | 2026-05-12 |
Family
ID=82218428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024565108A Pending JP2025515979A (ja) | 2022-05-02 | 2023-04-28 | ポドサイト特異的発現のための核酸コンストラクト及びベクター |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250288696A1 (enExample) |
| EP (2) | EP4273243A1 (enExample) |
| JP (1) | JP2025515979A (enExample) |
| KR (1) | KR20250006979A (enExample) |
| CN (1) | CN119677849A (enExample) |
| AU (1) | AU2023266069A1 (enExample) |
| CA (1) | CA3256851A1 (enExample) |
| WO (1) | WO2023213738A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201900702D0 (en) * | 2019-01-18 | 2019-03-06 | Univ Bristol | Therapy |
| GB202009039D0 (en) | 2020-06-15 | 2020-07-29 | Univ Bristol | Therapy |
| GB202304841D0 (en) * | 2023-03-31 | 2023-05-17 | Purespring Therapeutics Ltd | Promoter |
| GB202309909D0 (en) | 2023-06-29 | 2023-08-16 | Purespring Therapeutics Ltd | Regulatory elements |
| GB202309913D0 (en) * | 2023-06-29 | 2023-08-16 | Purespring Therapeutics Ltd | Polynucleotides, avv vectors, and pharmaceutical compositions for treating nephrotic syndrome |
| GB202309908D0 (en) * | 2023-06-29 | 2023-08-16 | Purespring Therapeutics Ltd | Polynucleotides, aav vectors, and pharmaceutical compositions for treating complement-mediated kidney diseases |
| GB202309914D0 (en) | 2023-06-29 | 2023-08-16 | Purespring Therapeutics Ltd | Promoters |
| WO2025168940A1 (en) | 2024-02-07 | 2025-08-14 | Purespring Therapeutics Limited | Vectors |
| GB202407863D0 (en) | 2024-06-03 | 2024-07-17 | Purespring Therapeutics Ltd | Methods |
| WO2026024176A1 (en) * | 2024-07-22 | 2026-01-29 | The Trustees Of The Columbia University In The City Of New York | Synthetic reporters for multiplexed detection of transcription factor activity |
| GB202414499D0 (en) | 2024-10-02 | 2024-11-13 | Purespring Therapeutics Ltd | Methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017153606A1 (en) | 2016-03-11 | 2017-09-14 | Fundació Institut De Recerca Biomèdica (Irb Barcelona) | Nucleic acid constructs and vectors for oncoselective expression of a transgene |
| GB201900702D0 (en) | 2019-01-18 | 2019-03-06 | Univ Bristol | Therapy |
| EP3914719A4 (en) * | 2019-01-24 | 2023-04-05 | Valorisation-HSJ, Limited Partnership | Cell-specific transcriptional regulatory sequences and uses thereof |
| GB202003618D0 (en) | 2020-03-12 | 2020-04-29 | Univ Bristol | Gene Therapy |
-
2022
- 2022-05-02 EP EP22382421.0A patent/EP4273243A1/en not_active Withdrawn
-
2023
- 2023-04-28 JP JP2024565108A patent/JP2025515979A/ja active Pending
- 2023-04-28 EP EP23726871.9A patent/EP4519433A1/en active Pending
- 2023-04-28 WO PCT/EP2023/061388 patent/WO2023213738A1/en not_active Ceased
- 2023-04-28 CA CA3256851A patent/CA3256851A1/en active Pending
- 2023-04-28 KR KR1020247040008A patent/KR20250006979A/ko active Pending
- 2023-04-28 US US18/862,451 patent/US20250288696A1/en active Pending
- 2023-04-28 CN CN202380051659.7A patent/CN119677849A/zh active Pending
- 2023-04-28 AU AU2023266069A patent/AU2023266069A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3052719T3 (en) | Polynucleotides and vectors for the expression of transgenes | |
| JP2024009857A5 (enExample) | ||
| JP2022500066A5 (enExample) | ||
| JP2022508182A5 (enExample) | ||
| US10413598B2 (en) | Factor IX gene therapy | |
| IL273261B2 (en) | Adeno-associated virus variant capsids and methods of using them | |
| JP2024099770A5 (enExample) | ||
| JP2021512649A5 (enExample) | ||
| JP2021505133A5 (enExample) | ||
| JP2022547197A5 (enExample) | ||
| JP2018522529A5 (enExample) | ||
| IL299325B2 (en) | Acid-alpha glucosidase variants and uses thereof | |
| JP2019513399A5 (enExample) | ||
| JP2022529631A5 (enExample) | ||
| JP7541027B2 (ja) | 筋肉発現のためのハイブリッドプロモーター | |
| JP2023514242A5 (enExample) | ||
| CN106459932B (zh) | 高胆红素血症的治疗 | |
| JP2021534814A5 (enExample) | ||
| JP2021520837A5 (enExample) | ||
| JP2022524434A5 (enExample) | ||
| JP2022541070A5 (enExample) | ||
| JP2022551744A5 (enExample) | ||
| RU2018145010A (ru) | Оптимизированные гены и экспрессионные кассеты cln1, и их применение | |
| JP2023537358A5 (enExample) | ||
| CN114231532B (zh) | 在哺乳动物肌肉中特异性启动基因的启动子序列及其应用 |